JP2024500922A5 - - Google Patents
Info
- Publication number
- JP2024500922A5 JP2024500922A5 JP2023538682A JP2023538682A JP2024500922A5 JP 2024500922 A5 JP2024500922 A5 JP 2024500922A5 JP 2023538682 A JP2023538682 A JP 2023538682A JP 2023538682 A JP2023538682 A JP 2023538682A JP 2024500922 A5 JP2024500922 A5 JP 2024500922A5
- Authority
- JP
- Japan
- Prior art keywords
- cell lymphoma
- lymphoma
- disease
- substituted
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20216838 | 2020-12-23 | ||
| EP20216838.1 | 2020-12-23 | ||
| PCT/EP2021/087312 WO2022136555A1 (en) | 2020-12-23 | 2021-12-22 | Improved cd30 targeting antibody drug conjugates and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024500922A JP2024500922A (ja) | 2024-01-10 |
| JP2024500922A5 true JP2024500922A5 (https=) | 2024-12-25 |
Family
ID=73856997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023538682A Pending JP2024500922A (ja) | 2020-12-23 | 2021-12-22 | 改善されたｃｄ３０ターゲティング抗体薬物コンジュゲートおよびその使用法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220193251A1 (https=) |
| EP (1) | EP4267193A1 (https=) |
| JP (1) | JP2024500922A (https=) |
| KR (1) | KR20230124684A (https=) |
| CN (1) | CN117642185A (https=) |
| AR (1) | AR124475A1 (https=) |
| AU (1) | AU2021406518A1 (https=) |
| CA (1) | CA3201178A1 (https=) |
| IL (1) | IL303447A (https=) |
| MX (1) | MX2023007126A (https=) |
| TW (1) | TW202237166A (https=) |
| UY (1) | UY39587A (https=) |
| WO (1) | WO2022136555A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119708088A (zh) * | 2023-09-28 | 2025-03-28 | 上海糖岭生物医药有限责任公司 | 二糖-酰腙或二糖-酰肼连接子、基于其的糖工程抗体及糖链定点抗体-药物偶联物及用途 |
| CN117843513B (zh) * | 2024-03-07 | 2024-05-28 | 深圳创元生物医药科技有限公司 | 一种(S)-3-Carboxytyrosine的制备方法 |
| WO2025213130A1 (en) * | 2024-04-04 | 2025-10-09 | Yale University | Antibody drug conjugates |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US633410A (en) | 1898-09-22 | 1899-09-19 | George A Ames | Ice-cutter. |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| DK1545613T3 (da) | 2002-07-31 | 2011-11-14 | Seattle Genetics Inc | Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom |
| NZ610239A (en) | 2008-04-30 | 2014-11-28 | Immunogen Inc | Cross-linkers and their uses |
| TWI535445B (zh) | 2010-01-12 | 2016-06-01 | 安可美德藥物股份有限公司 | Ｗｎｔ拮抗劑及治療和篩選方法 |
| US10668162B2 (en) | 2012-01-06 | 2020-06-02 | Linxis B.V. | Method for preparing cell targeting conjugates, and the complexes obtained |
| US9504756B2 (en) | 2012-05-15 | 2016-11-29 | Seattle Genetics, Inc. | Self-stabilizing linker conjugates |
| CN104640572B (zh) | 2012-05-15 | 2018-04-27 | 索伦托医疗有限公司 | 药物偶联物，偶联方法，及其用途 |
| PL2991683T3 (pl) | 2013-05-02 | 2020-03-31 | Glykos Finland Oy | Koniugaty glikoproteiny lub glikanu z toksycznym ładunkiem |
| WO2015057063A1 (en) | 2013-10-14 | 2015-04-23 | Synaffix B.V. | Modified glycoprotein, protein-conjugate and process for the preparation thereof |
| WO2015057066A1 (en) | 2013-10-14 | 2015-04-23 | Synaffix B.V. | Glycoengineered antibody, antibody-conjugate and methods for their preparation |
| NZ758049A (en) | 2013-10-15 | 2024-03-22 | Seagen Inc | Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics |
| KR102442906B1 (ko) | 2013-12-19 | 2022-09-14 | 씨젠 인크. | 표적화된-약물 컨쥬게이트와 함께 사용되는 메틸렌 카바메이트 링커 |
| EP3160513B1 (en) | 2014-06-30 | 2020-02-12 | Glykos Finland Oy | Saccharide derivative of a toxic payload and antibody conjugates thereof |
| CN107106701B (zh) | 2014-10-03 | 2020-11-06 | 西纳福克斯股份有限公司 | 磺酰胺接头、其缀合物及制备方法 |
| CA2964837C (en) | 2014-10-29 | 2023-10-17 | Ludwig-Maximilians-Universitaet Muenchen | Means and methods for site-specific functionalization of polypeptides |
| EP3378123A4 (en) * | 2015-11-17 | 2019-06-19 | Gapwaves AB | SELF-EMBOSSED SURFACE MOUNTABLE BOWTIE ANTENNA ASSEMBLY, ANTENNA SHEET AND MANUFACTURING METHOD |
| JP2017197512A (ja) * | 2016-02-08 | 2017-11-02 | シンアフィックス ビー．ブイ． | Ｃｄ３０腫瘍を標的化するための改善された治療指数を有する新規な抗体−コンジュゲート及び抗体−コンジュゲートの治療指数を改善するための方法 |
| EP3413915A1 (en) * | 2016-02-08 | 2018-12-19 | Synaffix B.V. | Antibody-conjugates with improved therapeutic index for targeting her2 tumours and method for improving therapeutic index of antibody-conjugates |
| WO2017186855A1 (en) * | 2016-04-28 | 2017-11-02 | Forschungsverbund Berlin E.V. | Unusual substrates of tubulin tyrosine ligase |
| WO2018167847A1 (ja) * | 2017-03-14 | 2018-09-20 | 株式会社島津製作所 | モノクローナル抗体の同時定量方法 |
| GB201820864D0 (en) * | 2018-12-20 | 2019-02-06 | J A Kemp | Antibody-drug conjugates |
-
2021
- 2021-12-22 UY UY0001039587A patent/UY39587A/es unknown
- 2021-12-22 MX MX2023007126A patent/MX2023007126A/es unknown
- 2021-12-22 EP EP21843993.3A patent/EP4267193A1/en active Pending
- 2021-12-22 TW TW110148222A patent/TW202237166A/zh unknown
- 2021-12-22 US US17/559,664 patent/US20220193251A1/en active Pending
- 2021-12-22 JP JP2023538682A patent/JP2024500922A/ja active Pending
- 2021-12-22 KR KR1020237025052A patent/KR20230124684A/ko active Pending
- 2021-12-22 CN CN202180094477.9A patent/CN117642185A/zh active Pending
- 2021-12-22 IL IL303447A patent/IL303447A/en unknown
- 2021-12-22 AU AU2021406518A patent/AU2021406518A1/en active Pending
- 2021-12-22 CA CA3201178A patent/CA3201178A1/en active Pending
- 2021-12-22 AR ARP210103627A patent/AR124475A1/es unknown
- 2021-12-22 WO PCT/EP2021/087312 patent/WO2022136555A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024500922A5 (https=) | ||
| JP2020534030A5 (https=) | ||
| ES2675825T3 (es) | Vacunación tumoral que involucra una respuesta inmunitaria contra la proteína propia CLDN18.2 | |
| WO2013113736A1 (en) | Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen | |
| US20170326233A1 (en) | Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxin | |
| IL272410B1 (en) | Cytokine conjugates for the treatment of autoimmune diseases | |
| JP2008546792A5 (https=) | ||
| JP6941321B2 (ja) | 疾患の要因となる生体内タンパク質を標的とするコンジュゲートワクチン | |
| US20170281787A1 (en) | Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxin | |
| US20210128668A1 (en) | Tetramaleimide linkers and use thereof | |
| CY1106723T1 (el) | Ν-τελικα μονοπεγυλιωμενα συζευγματα ανθρωπινης αυξητικης ορμονης, διεργασιες για την παρασκευη τους και μεθοδοι χρησης αυτων | |
| CN108578710A (zh) | 用经不可切割接头连接的细胞结合剂美登木素生物碱偶联物 | |
| US10463747B2 (en) | Method of developing a vaccine using peptide-poly IC complexes | |
| JP2013100314A5 (https=) | ||
| JP2023526500A (ja) | アルツハイマー病の処置のためのマルチエピトープワクチン | |
| NO20160447A1 (no) | Fremgangsmåte for målsøking av spesifikke cellepopulasjoner ved å benytte cellebindings-middelmaytansinoidkonjugater bundet via en ikke-kløyvbar linker, nevnte konjugater og fremstilling av nevnte konjugater | |
| JP2023536995A (ja) | アルツハイマー病を処置するためのマルチエピトープワクチン | |
| JP2023541670A (ja) | アルツハイマー病の処置のためのマルチエピトープワクチン | |
| WO2015036646A1 (es) | Combinaciones de proteínas agregantes y chaperonas moleculares para el tratamiento de proteinopatías o enfermedades conformacionales | |
| CA2598060A1 (en) | Methods and compositions for the treatment and prevention of cancer | |
| JP2023541671A (ja) | シヌクレイノパチーの処置のためのアルファ－シヌクレインワクチン | |
| WO2013188715A2 (en) | Compositions and methods for treating cancer | |
| RU2023116518A (ru) | Улучшенные конъюгаты антитело-лекарственное средство, направленные на CD30, и их применение | |
| TWI811957B (zh) | 重組多肽，包含該重組多肽的複合物，以及其用途 | |
| JP5836968B2 (ja) | ＩｇＥ媒介性疾患の処置方法 |